IP Library Granted Patent US 6,967,093
Granted Patent B2
US 6,967,093 · App. 09/816,825 · Granted Nov 22, 2005

Glycosyl sulfotransferase-3

Assignees: The Regents of the University of California; Syntex (U.S.A) LLC
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,967,093
App. No.
09/816,825
Granted
Nov 22, 2005
Kind
B2
Abstract

A novel human glycosylsulfotransferase expressed in high endothelial cells (GST-3) and polypeptides related thereto, as well as nucleic acid compositions encoding the same, are provided. The subject polypeptides and nucleic acid compositions find use in a variety of applications, including research, diagnostic, and therapeutic agent screening applications. Also provided are methods of inhibiting selectin mediated binding events and methods of treating disease conditions associated therewith.

Claims (15)

1. An isolated nucleic acid molecule that hybridizes under stringent conditions to a nucleic acid molecule comprising the nucleotide sequence set forth in SEQ ID NO:01, or its complementary sequence, wherein stringent hybridization conditions comprise hybridization at 50° C. or higher in a solution comprising 15 mM sodium chloride and 1.5 mM sodium citrate, wherein said nucleotide sequence encodes a polypeptide that catalyzes the transfer of a sulfate group from a sulfate donor to a sulfate acceptor.

2. An expression vector comprising the nucleic acid of claim 1 .

3. An isolated host cell comprising the expression vector of claim 2 .

4. The host cell of claim 3 , wherein the cell is prokaryotic.

5. The host cell of claim 3 , wherein the cell is eukaryotic.

6. A method of producing a glycosyl sulfotransferase-3 polypeptide, said method comprising:

growing a cell according to claim 3 , whereby said polypeptide is expressed; and

isolating said polypeptide.

7. The isolated nucleic acid of claim 1 , wherein said nucleic acid comprises the nucleotide sequence set forth in SEQ ID NO:1.

8. A composition comprising the nucleic acid of claim 1 .

9. The composition according to claim 8 , wherein said composition further comprises a test agent.

10. The composition according to claim 8 , wherein said composition further comprises a sulfate donor.

11. The composition according to claim 8 , wherein said composition further comprises a sulfate acceptor.

12. The composition according to claim 11 , wherein said sulfate acceptor is a selectin.

13. The expression vector of claim 2 , wherein said nucleic acid is operably linked to an exogenous control region.

Assignments (3)
CONFIRMATORY LICENSE Recorded Oct 11, 2016
From: UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
To: NIH-DEITR
Reel/Frame 039988/0163 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 12, 2005
From: BISTRUP, ANNETTE; ROSEN, STEVEN D.
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 016526/0937 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 12, 2005
From: HEMMERICH, STEFAN
To: SYNTEX (U.S.A.) INC.
Reel/Frame 016526/0961 →
Continuity (2)
Continuation 0904528400 · Mar 20, 1998
Related Publication 20010051370A1 · Dec 13, 2001